4399在线视频免费观看

山東(dong)秉(bing)泰生(sheng)(sheng)物(wu)科(ke)技(ji)(ji)(ji)有限公司成立(li)于2017年，技(ji)(ji)(ji)術背景主(zhu)要來(lai)自于美(mei)國大學(xue)研(yan)(yan)究院所、中科(ke)院、國內985高校(xiao)等生(sheng)(sheng)物(wu)醫藥(yao)與(yu)(yu)臨(lin)床轉化研(yan)(yan)發機構，核心團隊由長期(qi)(qi)從事(shi)生(sheng)(sheng)物(wu)醫藥(yao)基礎(chu)與(yu)(yu)臨(lin)床轉化研(yan)(yan)究的全職教授、江(jiang)蘇省“雙創人才”等組(zu)成，50%有海(hai)外留(liu)學(xue)經歷及博士學(xue)位。有完(wan)善的生(sheng)(sheng)物(wu)醫藥(yao)科(ke)技(ji)(ji)(ji)服務及研(yan)(yan)發平臺，近(jin)期(qi)(qi)有多(duo)篇論文(wen)在國際刊物(wu)發表，并擁有抗腫瘤藥(yao)生(sheng)(sheng)產、臨(lin)床診斷等多(duo)項(xiang)發明(ming)專利；技(ji)(ji)(ji)術服務及產品主(zhu)要針對美(mei)國、北京、上海(hai)、江(jiang)蘇、山東(dong)等科(ke)研(yan)(yan)院所與(yu)(yu)醫院的高端客(ke)戶。

2018年泰(tai)安(an)市科技(ji)(ji)局、泰(tai)山科學院與山東秉泰(tai)生物科技(ji)(ji)有限公司三方合作成(cheng)立大(da)(da)分子(zi)(zi)藥(yao)物產業技(ji)(ji)術(shu)研(yan)(yan)(yan)(yan)究(jiu)院。 公司與研(yan)(yan)(yan)(yan)究(jiu)院主要圍繞大(da)(da)分子(zi)(zi)藥(yao)物領域進行(xing)藥(yao)物研(yan)(yan)(yan)(yan)發并對重(zhong)大(da)(da)疾病(bing)(bing)(bing)相關(guan)(guan)的(de)生物技(ji)(ji)術(shu)研(yan)(yan)(yan)(yan)究(jiu)進行(xing)成(cheng)果轉(zhuan)化。搭建了(le)包括抗體、基(ji)因編輯(ji)、細胞(bao)信(xin)號(hao)轉(zhuan)導和分子(zi)(zi)診(zhen)治(zhi)研(yan)(yan)(yan)(yan)究(jiu)的(de)研(yan)(yan)(yan)(yan)發平臺，制訂相關(guan)(guan)生物大(da)(da)分子(zi)(zi)基(ji)礎(chu)研(yan)(yan)(yan)(yan)究(jiu)及(ji)成(cheng)果轉(zhuan)化研(yan)(yan)(yan)(yan)究(jiu)策(ce)略，構建系(xi)統(tong)標(biao)準的(de)生物大(da)(da)分子(zi)(zi)研(yan)(yan)(yan)(yan)發方法和流程。主要圍繞包括多(duo)克(ke)隆抗體、基(ji)因編輯(ji)、細胞(bao)信(xin)號(hao)轉(zhuan)導、分子(zi)(zi)診(zhen)治(zhi)、生物大(da)(da)分子(zi)(zi)與疾病(bing)(bing)(bing)發病(bing)(bing)(bing)機理(li)相互關(guan)(guan)系(xi)、重(zhong)大(da)(da)疾病(bing)(bing)(bing)分子(zi)(zi)藥(yao)物靶標(biao)等關(guan)(guan)鍵技(ji)(ji)術(shu)開展研(yan)(yan)(yan)(yan)發攻(gong)關(guan)(guan)和技(ji)(ji)術(shu)服務；開發了(le)關(guan)(guan)鍵功能生物大(da)(da)分子(zi)(zi)與疾病(bing)(bing)(bing)發病(bing)(bing)(bing)機理(li)相互關(guan)(guan)系(xi)的(de)研(yan)(yan)(yan)(yan)究(jiu)技(ji)(ji)術(shu)，對重(zhong)大(da)(da)疾病(bing)(bing)(bing)（如腫(zhong)瘤、糖尿病(bing)(bing)(bing)等）進行(xing)藥(yao)物研(yan)(yan)(yan)(yan)發。